Table of Content

Table of Contents

Global Viral Vector Vaccines Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Viral Vector Vaccines Market by Value
2.2.1 Global Viral Vector Vaccines Revenue by Type
2.2.2 Global Viral Vector Vaccines Market by Value (%)
2.3 Global Viral Vector Vaccines Market by Production
2.3.1 Global Viral Vector Vaccines Production by Type
2.3.2 Global Viral Vector Vaccines Market by Production (%)

3. The Major Driver of Viral Vector Vaccines Industry
3.1 Historical & Forecast Global Viral Vector Vaccines Demand
3.2 Largest Application for Viral Vector Vaccines (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Viral Vector Vaccines Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Viral Vector Vaccines Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Viral Vector Vaccines Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Viral Vector Vaccines Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Viral Vector Vaccines Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Viral Vector Vaccines Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Viral Vector Vaccines Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Viral Vector Vaccines Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Viral Vector Vaccines Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Viral Vector Vaccines Average Price Trend
12.1 Market Price for Each Type of Viral Vector Vaccines in US (2018-2022)
12.2 Market Price for Each Type of Viral Vector Vaccines in Europe (2018-2022)
12.3 Market Price for Each Type of Viral Vector Vaccines in China (2018-2022)
12.4 Market Price for Each Type of Viral Vector Vaccines in Japan (2018-2022)
12.5 Market Price for Each Type of Viral Vector Vaccines in India (2018-2022)
12.6 Market Price for Each Type of Viral Vector Vaccines in Korea (2018-2022)
12.7 Market Price for Each Type of Viral Vector Vaccines in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Viral Vector Vaccines Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Viral Vector Vaccines

14. Viral Vector Vaccines Competitive Landscape
14.1 Advanced Bioscience Laboratories
14.1.1 Advanced Bioscience Laboratories Company Profiles
14.1.2 Advanced Bioscience Laboratories Product Introduction
14.1.3 Advanced Bioscience Laboratories Viral Vector Vaccines Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Boehringer Ingelheim
14.2.1 Boehringer Ingelheim Company Profiles
14.2.2 Boehringer Ingelheim Product Introduction
14.2.3 Boehringer Ingelheim Viral Vector Vaccines Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Brammer Bio
14.3.1 Brammer Bio Company Profiles
14.3.2 Brammer Bio Product Introduction
14.3.3 Brammer Bio Viral Vector Vaccines Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Creative Biogene
14.4.1 Creative Biogene Company Profiles
14.4.2 Creative Biogene Product Introduction
14.4.3 Creative Biogene Viral Vector Vaccines Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 GE Healthcare
14.5.1 GE Healthcare Company Profiles
14.5.2 GE Healthcare Product Introduction
14.5.3 GE Healthcare Viral Vector Vaccines Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Pfizer
14.6.1 Pfizer Company Profiles
14.6.2 Pfizer Product Introduction
14.6.3 Pfizer Viral Vector Vaccines Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Sanofi
14.7.1 Sanofi Company Profiles
14.7.2 Sanofi Product Introduction
14.7.3 Sanofi Viral Vector Vaccines Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Viral Vector Vaccines Industry (Volume)
Figure 2. Viral Vector Vaccines Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Viral Vector Vaccines Revenue in 2022
Figure 5. US Viral Vector Vaccines Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Viral Vector Vaccines Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Viral Vector Vaccines Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Viral Vector Vaccines Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Viral Vector Vaccines Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Viral Vector Vaccines Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Viral Vector Vaccines Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Viral Vector Vaccines Revenue, by Type (Million USD) (2018-2028)
Table 4. Viral Vector Vaccines Production, by Type (K Unit) (2018-2028)
Table 5. Viral Vector Vaccines Demand (K Unit) by Application (2018-2028)
Table 6. Viral Vector Vaccines Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Viral Vector Vaccines Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Viral Vector Vaccines Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Viral Vector Vaccines Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Viral Vector Vaccines Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Viral Vector Vaccines Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Viral Vector Vaccines Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Viral Vector Vaccines Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Viral Vector Vaccines Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Viral Vector Vaccines in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Viral Vector Vaccines in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Viral Vector Vaccines in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Viral Vector Vaccines in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Viral Vector Vaccines in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Viral Vector Vaccines in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Viral Vector Vaccines in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Advanced Bioscience Laboratories Profiles
Table 61. Advanced Bioscience Laboratories Viral Vector Vaccines Product Introduction
Table 62. Advanced Bioscience Laboratories Viral Vector Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Advanced Bioscience Laboratories Strategic initiatives
Table 64. Boehringer Ingelheim Profiles
Table 65. Boehringer Ingelheim Viral Vector Vaccines Product Introduction
Table 66. Boehringer Ingelheim Viral Vector Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Boehringer Ingelheim Strategic initiatives
Table 68. Brammer Bio Profiles
Table 69. Brammer Bio Viral Vector Vaccines Product Introduction
Table 70. Brammer Bio Viral Vector Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Brammer Bio Strategic initiatives
Table 72. Creative Biogene Profiles
Table 73. Creative Biogene Viral Vector Vaccines Product Introduction
Table 74. Creative Biogene Viral Vector Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Creative Biogene Strategic initiatives
Table 76. GE Healthcare Profiles
Table 77. GE Healthcare Viral Vector Vaccines Product Introduction
Table 78. GE Healthcare Viral Vector Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. GE Healthcare Strategic initiatives
Table 80. Pfizer Profiles
Table 81. Pfizer Viral Vector Vaccines Product Introduction
Table 82. Pfizer Viral Vector Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Pfizer Strategic initiatives
Table 84. Sanofi Profiles
Table 85. Sanofi Viral Vector Vaccines Product Introduction
Table 86. Sanofi Viral Vector Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Sanofi Strategic initiatives